Table 2.

Protein expression and prognosis

Antibody	ADC, HR (95% CI)	P	SqCC, HR (95% CI)	P	NSCLC, HR (95% CI)	P
p-AKT (P vs N)	2.75 (1.44-5.94)	0.001	1.57 (0.92-2.84)	0.093	2.02 (1.34-3.19)	<0.001
PTEN (P vs N)	0.72 (0.34-1.86)	0.465	1.61 (0.71-4.64)	0.276	1.11 (0.63-2.2)	0.72
p-TSC2 (P vs N)	1.95 (0.81-3.95)	0.122	1.11 (0.06-5.26)	0.888	1.82 (0.81-3.47)	0.131
p-mTOR (P vs N)	1.09 (0.71-1.67)	0.669	0.99 (0.65-1.54)	0.999	1.01 (0.75-1.36)	0.913
p-S6 (P vs N)	1.68 (1.06-2.60)	0.025	1.36 (0.82-2.17)	0.221	1.5 (1.07-2.06)	0.016
p-eIF4E (P vs N)	1.8 (1.18-2.74)	0.006	1.55 (1.00-2.39)	0.048	1.68 (1.24-2.27)	<0.001
p-ERK1/2 (P vs N)	1.12 (0.68-1.78)	0.621	1.3 (0.63-2.41)	0.443	1.2 (0.81-1.73)	0.346

NOTE: Univariate analysis.

Abbreviations: HR, hazard ratio; 95% CI, 95% confidence interval.